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ITV and ADS techniques resulted in substantial (up to 25%) maximum dose increases where solid tissue
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Abstract
In inverse planning of lung radiotherapy, techniques are required to ensure dose coverage of target disease in the presence of tumor motion as a result of respiration. A
range of published techniques for mitigating motion effects were compared for dose
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stability across 5 breath cycles of 2 cm. Techniques included planning target volume
(PTV) expansions, internal target volumes with (OITV) and without tissue override
(ITV), average dataset scans (ADS), and mini-max robust optimization. Volumetric arc
therapy plans were created on a thorax phantom and veriﬁed with chamber and ﬁlm
measurements. Dose stability was compared by DVH analysis in calculations across all
geometries. The lung override technique resulted in a substantial lack of dose coverage (10%) to the tumor in the presence of large motion. PTV, ITV and ADS techniques resulted in substantial (up to 25%) maximum dose increases where solid tissue
travelled into low density optimized regions. The results highlight the need for care in
optimization of highly heterogeneous where density variations may occur with
motion. Robust optimization was shown to provide greater stability in both maximum
(<3%) and minimum dose variations (<2%) over all other techniques.
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1 | INTRODUCTION

enormous amount of work has investigated the variations in organs
and tumors with breathing. The AAPM Task Group 765 presented
1

Lung Cancer is the leading cause of cancer death in Australia whilst the

the following summation on review of the literature; “The amount a

American Cancer Society records 5-year survival of lung tumor cases at

lung tumor moves during breathing varies widely. . .There are no

17%.2 Surgery morbidity and a need for multimodality treatments results

general patterns of respiratory behavior that can be assumed for a

in over half of all lung cancer patients receiving radiotherapy as some

particular patient prior to observation and treatment”. Many of the

part of their clinical treatment.2 Volumetric Modulated Arc Radiotherapy

reviewed studies6–13 had focused on quantifying the magnitude of

(VMAT) and Intensity Modulated Radiotherapy (IMRT) have been shown

such tumor motion, showing variations as great as 34 mm, 22 mm,

to provide improvements in radiotherapy plan dose distribution over

and 12 mm in the cranio-caudal, anterior-posterior, and lateral direc-

3-Dimensional Conformal Radiotherapy Techniques (3DCRT).3,4

tions respectively, in some patients.14 Traditional planning methods

As a result of patient breathing, large variations in primary tumor

provide suitable coverage of mobile Gross Tumour Volumes (GTV) by

position are often seen during radiotherapy of lung disease. An

creation of Internal Target Volumes (ITV) which encompasses the GTV

---------------------------------------------------------------------------------------------------------------------------------------------------------------------This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2017 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine.
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through its respiratory motion. Typically, a further expansion is made

In the situation of internal lung tissue the effect is less studied.

to account for geometric set-up uncertainty of the patient, to create a

The electron densities among air, lung, and muscle tissue is similar48

Planning Target Volume (PTV) for which dose coverage metrics are

suggesting the effect is predominantly the result of physical density.

assessed.

It thus follows that an equivalent but reduced effect may be

Recent improvements in the technology of 4-Dimensional Computed Tomography (4DCT) image binning,15–18 respiratory motion
monitoring,18–23 functional imaging correlation,24–26 and faster imaging techniques have resulted in several delivery methodologies to
decrease the impact of lung motion. Another approach to reducing the
impact is to minimize the motion itself by incorporating compression
belts27 to restrict diaphragm contraction and expansion, implementing
breath hold techniques23,28–30 or gating the treatment by restricting
delivery to particular components of the breathing cycle.14,20,25,31,32
Recent works from several research groups have also investigated the

observed in lung/disease boundaries. In lung patients the result of
this effect is complicated by a couple of further considerations;
1. Incident beams on lung tumors will undergo primary attenuation
and build-up of secondary electrons by superﬁcial tissue, such as
the muscles of the chest wall. These secondary electrons are of
an order of magnitude less for surface optimization.
2. The movement is not limited to the target itself but can also
include the surrounding tissue with no necessary correlation in
direction or magnitude of motion.

tracking of tumor by dynamic correction of MLC positions.33–37 In the

Robust optimization is a recent introduction into the world of

majority of these solutions the objective is to minimize the ITV vol-

radiotherapy planning made possible by the increased parallel com-

ume, and thus the PTV volume. Whilst some of the systems, as individ-

putational power of Graphic Processer Units (GPUs) along with more

ual or combined solutions, are showing promising results in reduction

efﬁcient threaded allocation of dose computations. Robust optimiza-

14,23,28,38

in irradiated volumes and healthy tissue doses,

they provide a

solution to only one half of the motion induced problem.
Calculation and delivery of modulated distributions on moving
targets are subject to three well documented uncertainties between
planning and delivery; blurring, interplay, and dose deformation.

tion allows a plan to be optimized such that it meets planning criteria in not only the planning geometry, but also in given patient and
disease position variations.45 The commercial system used in this
paper is Raystation v5.0.1 (Raysearch, Sweden).
Raystation ensures robust planning doses by the incorporation

McCarter and Beckham39 demonstrated large delivery variations

of min-max optimization whereby the geometric uncertainties of

in high dose gradient regions in the presence of tumor motion as a

the plan are incorporated in the problem function. The formalism

have shown that

includes no dependence on a probability distribution of the poten-

extreme dose variations of up to 100% in IMRT ﬁeld delivery due to

tial geometric uncertainty as per Bortfeld et al.,49 Chu et al.,50

the interplay effect are theoretically possible. Subsequent statistical

Chan et al.,51 and Olafsson and Wright,52 but rather minimizes the

analysis by Bortfeld42 found no signiﬁcant difference over long course

objective function of the worst preforming geometry within the

treatments (>10 fractions) however, comparisons were made against

included distribution. This ensures a minimum level of plan quality,

an introduced formalism rather than a CT dose distribution (of which

but results in a dependence on limitations of uncertainty and the

variations of up to 20% were noted). A study by Englesman et al.43

potential for the system to over optimize low probability scenarios

focused on dose deformation showed small variations (<5%) in dose

at the cost of plan quality of higher probability scenarios. In a

distributions with tumor motion and a broadening of the high dose dis-

paper by Fredriksson,53 in which the formalism was introduced, the

tribution along the axis of travel with 3D conformal planning.

method was shown to provide robust plans with increased lung

40,41

result of the blurring effect. Several authors

Optimization is the computerization of mathematical problem

sparing over PTV expansions for intensity modulated proton ther-

solving. In the realm of radiotherapy planning the speciﬁc problem is

apy, whilst work by Byrne et al45 has demonstrated its potential in

the maximization of dose to a target volume whilst minimizing the

IMRT planning. The implementation of min-max optimization by

dose to the surrounding tissue. By this deﬁnition a large component

the vendor is provided in two options; speciﬁed 3-dimensional off-

of the optimization process is ensuring a minimum dose to the vox-

sets set by the user or planning over a range of patient scans

els encompassed by a deﬁned target volume.

(Fig. 1).

A fourth potential issue in mobile lung disease is the impact of

The aim of this work is to establish the accuracy of the Raystation

dose optimization to lung tissue and bronchial airways in the pres-

collapsed cone convolution algorithm in calculations across multiple

ence of tumor motion, where the objective function is required to

datasets and to utilize this methodology to analyse the suitability of

ensure target dose coverage to large PTVs that include a volume of

various optimization schemes in ensuring accurate and uniform dose

lung or air with a density signiﬁcantly less than the GTV tissue.

to moving targets through breathing cycles in lung tissue.

44,45

Previous literature

has shown the adverse dosimetric impli-

cations of optimizing to and outside of surface contours, where the
lack of electron density results in high photon ﬂuence to achieve
equivalent doses. In such cases when the patient tissue traverses
into the region containing air during treatment, the high intensity ﬂu-

2 | METHOD
2.A | Datasets

ence results in a sharp increase in primary interactions, liberated sec-

Planning CT scans were taken with the CIRS thoracic phantom (CIRS

ondary electron generation, and resultant dose deposition.46,47

Inc., Virginia, USA) with a set of custom made wax (average density
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Robust optimization incorporation in Raystation using positional uncertainty (left) and multiple image sets (right).

0.95 g/cm3) inserts. All scans were performed on an AS Deﬁnition CT

An example of each of the datasets are shown in Fig. 3 along

scanner (Siemens Healthcare, Erlangen) at a maximum tube energy of

with an example of the average dataset at the end. The sagittal ori-

120 kVp, 216 mAs at 2 mm slices. Two separate wax inserts were

entation is shown for clarity of the average effect.

used. The ﬁrst wax insert was created with a chamber plug for an Exradin A1SL chamber (Standard Imaging, Wisconsin, USA), whilst the second insert included a Gafchromic ﬁlm holder in the sagittal plane. The
phantom was scanned in a breath cycle acquisition of ﬁve for each of
the two chamber inserts, resulting in a total of 10 scans. It should be
noted that the acquisitions were not true 4D binning, and had no time
correlation. To emulate binned breathing the scans were taken with
the phantom in an identical location but with the wax inserts manually
translated in 1 cm increments from 2 cm inferior of the planning scan
(0 cm offset) to 2 cm superior to the planning scan. For clarity the
individual scans will be referred to by their offsets and collectively
group referred to as the breathing cycle. In each of the CT scans of the
ﬁlm inserts, a dummy ﬁlm was included to ensure the planning density
matched that used for ﬁlm exposures. This particular study is interested in the effect of optimizing to lung. To assess the extent of the
effect the phantom insert region above the inserts was left as air, as
demonstrated in Fig. 2.
For both the chamber and ﬁlm cases the scans included the central planning position and two superior and inferior offset scans of
1 cm and 2 cm. Visual examples of the translations are shown in
Fig. 2.

2.B | Breathing cycles and plan parameters
All breathing cycle scans were imported into the Raystation system as 4DCT groups. Geometric contours representing the heart,
left and right lungs, spinal cord and ribs were propagated across
all datasets. The target volume was deﬁned as GTV in each dataset individually, and an ITV was created as a summation of all
GTVs registered back to the primary central dataset. A uniform
expansion of 0.5 cm was applied to the GTV/ITV to create a
PTV in each case. The margin was selected as per clinical protocol to account for imaging set-up tolerances. All tumor motion
margin was assumed to be included in the robust method incorporated.
To promote conformal dose distributions and to correlate with
typical planning convention a ring geometry was created around
the target ITV volume. An example of the target geometries is
shown in Fig. 3, inclusive of a demonstration of the average
4DCT scan.
A set of plans were created for both the chamber dataset and
ﬁlm dataset, and are individually outlined below;

For each of the 4DCT sets an “average” scan was created in

1. Plan ITV: Optimization was performed to ensure minimum dose

RayStation whereby the Hounsﬁeld units of all ﬁve scans are sum-

to the full extent of the GTV travel. An ITV was created by sum-

th

dataset. This was included to allow

mation of the GTV across all scans and a 5 mm PTV expansion

for the assessment of the potential use of this simpler and faster

applied in all orthogonal planes, inclusive of the air volume supe-

technique to account for varying geometry densities.

riorly and lung volume inferiorly.

mated and averaged on to a 6
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F I G . 2 . Shifts of GTV insert across
scans. 1: Lung Tissue Insert, 2: GTV Wax
Insert, 3: Isocentre, 4: Gafchromic Film, 5:
Chamber insert, 6: Air Cavity.

F I G . 3 . Travel of GTV superior to inferior (left to right) across all ﬁve scans, and the average compiled dataset (far right). Note the full travel
of the GTV (red) is encompassed by ITV (maroon) geometry.

2. Plan GTV: Plan was optimized to the GTV in the central axis with
a PTV expansion of 5 mm. It is expected that this will result in

1.0 g/cm3 in the 5th will result in an average CT density of the
voxel of 0.2 g/cm3.

minimum coverage failures throughout the breathing cycle. This

4. Plan robust all: Optimization was performed across all ﬁve data-

further highlights effects of edge of border effects at lung/tissue

sets with GTV geometry travel. Only the maximum dose to lung,

boundaries and expected dosimetry in a reduced phase treat-

minimum PTV coverage and maximum PTV dose were included

ment, such as gating.

as robust objectives. All other objectives were only optimized on

3. Plan average: Plan was optimized to the ITV + 5 mm on an aver-

the central travel dataset.

age dataset where the travel of the inserts resulted in a lower

5. Plan robust ext: Optimization was performed as per Robust All

density at the central GTV position, but a spread medium density

with the exception that only the central, the 2 cm superior, and

along the full length of travel. The volume was mapped to the

the 2 cm inferior geometries were included in robust objectives.

average dataset by static registration to ensure comparable plan-

The intention of this test was to determine if the exclusion of

ning volumes. This technique has been proposed previously in

intermediate breathing cycles would improve optimization speed

54,55

the literature.

It should be noted that the average dataset

without a reduction in the plan quality.

approach does not consider the respective time component of

6. Plan robust values: Robust optimization was performed with

each phase, but purely averages across all ﬁve scans. Thus, an

user-deﬁned geometry offsets in the superior and inferior direc-

area that is air in four of ﬁve scans and tissue of density

tion rather than across several scans. Robust optimization

108
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objectives were maintained as per the Robust All plan. This

optimization ceased. As a result, the variation between ﬁnal plan

methodology offers the assessment of the potential of robust

quality among all plans was negligible.

planning in the absence of multiple CT datasets rather than the
conventional use of a uniform PTV expansion.

A concerted attempt was made to meet all clinical goals in each
plan. In situations where goals could not be met, the plan was opti-

7. Plan lung override. Plans were optimized as per the methodology

mized such that the max dose control was the least critical. All but

by Wiant et al46 where by the ITV excluding the GTV on the free

one plan of 14 (2 9 7 optimization techniques) met all clinical goals

breathing scan was overridden to an intermediate density. This

which exceeded the max constraint by <0.05% of TD.

methodology was shown to provide signiﬁcant improvements
over ITV optimization with the analytical anisotropic algorithm of

For each case the ﬁnal calculated dose, DVH curves, and dose
statistics were recorded.

the Eclipse planning system (Varian Oncology Systems, CA, USA).
For this work a density override was set to 0.6 g/cm3 to correlate with a midpoint density between solid tissue and the surrounding 0.2 g/cm3 lung.

2.D | Calculation on breath cycle
Each of the completed plans was recalculated on each phase of the
4DCT datasets. In Raystation, for CT datasets with identical UID and

Unless explicitly mentioned above, all plans were performed on

frame of reference, the plan isocenter is intrinsically correlated

the central planning scan. Each scan relied on a dual arc VMAT

between datasets by the common DICOM co-ordinates, providing

delivery of two 360°deliveries with the isocenter set to the centre

consistency in set-up with the exception of the moving lung insert.

of the GTV in the primary scan. To prevent excessive modulation,

Comparisons were then made between DVH curves, organ statistics,

the leaf travel was limited to 0.5 cm/degree and the control point

and 2D dose distributions in each geometry. As the images were not

spacing set to 4° as per clinical practice. Plans were planned for a

taken as 4D binned sets calculation accuracy was reviewed on a per

Varian iX iClinac with millennium MLC. Dose calculation was per-

set basis independent of phase weightings.

formed on a 3 mm dose grid.
A further set of square 10 9 10 Ant-Post beams was added as a
standard reference-conditioned ﬁeld to verify the accuracy of reference dose.

2.E | Measurements
Each of the created plans were exported to Mosaiq 2.4 (IMPAC, CA,
USA). Plans were imported as per standard clinical practice and

2.C | Optimization

delivered to the CIRS phantom in the corresponding breath cycle
phantom positions.

Prior to planning a set of clinical goals were set for the acceptance
of plans. The goals were set arbitrarily to push the optimization system and create difﬁcult but achievable modulated plans. The evalua-

2.E.1 | Chamber measurements

tion of clinical goals was performed solely on the planning

For each plan two sets of chamber measurements were taken; one

(offset = 0 cm) geometry. These were loosely guided by common

at the central tumor and one at the inferior lung. Chamber measure-

goals for typical dose and fractionation levels at the centre.

ments at lung position were taken simultaneously with ﬁlm measure-

A list of the applied clinical goals is provided in Fig. 4.

ments at a distance 1.5 cm inferior to the ﬁlm insert as shown in

For robust planning the motion of the ITV becomes redundant

Fig. 5 in the ﬁlm plans. Central tumor measurements were taken

as the travel of the GTV is encompassed within the optimization sys-

with the A1SL chamber insert described above in separately opti-

tem rather than a geometry expansion. For this reason, the ITV cov-

mized plans at the planned and offset positions as per ﬁlm measure-

erage was not optimized for robust plans.

ments. Dosimetry measurements were taken with Exradin A1SL

Plans were accepted when they met the criteria set out in Fig. 4.

(Standard Imaging, WI, USA) and PTW TN31010 Semiﬂex chambers

In some scenarios these goals were exceeded. As plan quality was

with active volumes of 0.057 cm3 and 0.125 cm3 respectively.

not a metric in this study, once clinical goals were satisﬁed the

A PTW Webline electrometer (PTW, Freiburg, Germany), was utilized
for charge collection and all corrections were applied as per the formalism of IAEA TRS 398 v1256 to convert the chamber reading into
dose. All measurements were repeated twice. Before each measurement the chamber position was veriﬁed with on-line Cone beam
images to the original scans in RayStation.
Calculated chamber doses were determined by average dose to
accurately modeled active volumes of the chamber geometries.
Uncertainty for comparison was limited to positional errors of volume placement. As each delivery was imaged prior with CBCT positional accuracy of 1 mm, errors were determined on a worst case

FIG. 4.

Plan clinical goals for optimization.

2 mm geometric set-up error. Taking variations in average dose by

ARCHIBALD-HEEREN
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Position of chamber measurements for (a) GTV and (b) lung measurements.

shifting the active volume 2 mm in all planes across all plans resulted

analysis was performed with the widely used 3%/3 mm criteria

in an uncertainty of planned chamber dose of 1.5% as a result of

but limited to the superior inferior 1D distribution as a limita-

small positional errors. Measurements in low density material with

tion of the phantom and possible ﬁlm width. This analysis is

Ion chambers are known to suffer from perturbation effects57 from

considered acceptable for the work as the area under investiga-

the replacement of lung tissue and the nonwater equivalence the

tion is contained in the superior and inferior geometries, with

chamber walls, stem, and central electrode. As no current 6MV per-

no density changes in the remaining directional components. To

turbation factors are published for the A1DSL chamber, all lung mea-

ensure precision of ﬁlm against the 2D dose planes, all distribu-

surements were taken with the PTW Semiﬂex chamber. Work by

tions exported from the TPS were recalculated with a 2 mm

58

modelling the chamber with Monte Carlo calculations

dose grid for comparison. The effect of grid resolution has been

showed perturbation correction factors as much as 3% for 3 9 3

shown in previous work45 in areas of dose build up and density

ﬁelds and 1% for 5 9 5 ﬁelds in 6MV beams. The predominant

junctions.

Araki

size of beams used in this work was approximately 5 9 3 cm and
thus 3% represents a worst case scenario in the subsequent measurements. These perturbation factors were not applied to the ﬁnal
measurements, but were included within the total chamber uncertainty of 4.5%. Chamber measurements in more standard condi-

3 | RESULTS
3.A | Chamber measurements

tions, in the tumor measurements, were accurate within a more

The results of comparison between calculated (in the associated

typical uncertainty of 1.5%, accounting for standards calibration,

tumor geometry) and delivered doses to the chamber volumes are

temperature, and pressure uncertainties.

shown in Tables 1 and 2. For clarity individual reading variation is

Total uncertainty, inclusive of calculation and measurement,
when summated in quadrature was 2.1 and 4.7% for tissue and lung

not provided, however, across all chamber readings variation per
measurement were <0.3%.

measurements respectively.

3.B | Lung measurements
2.E.2 | Film measurements

3.B.1 | Film Measurements

As per the chamber measurements, all ﬁlm measurement plans had

Analysis of distributions along the length of travel of the primary

veriﬁcation cone beam CT images taken for each breath cycle to

tumor site are presented in Table 3. Results are presented as the

ensure correct ﬁlm orientation to within 5° and  1 mm. The dose

percentage of points passing the gamma analysis at a 3%/3 mm tol-

attributed to the ﬁlm from the CBCT acquisition was considered

erance.

negligible when analysing distributions of 6 Gy fractions and was
not accounted for in the comparisons. Gafchromic EBT3 ﬁlm (Ashland Advanced Materials, NJ, USA), of which the accuracy has been

3.B.2 | Tumor dose distributions

veriﬁed in numerous works,59–63 was used for measurements. Film

There is strong agreement between both ﬁlm and chamber dosime-

scanning was performed with an Expression 10000XL ﬂatbed scan-

try and calculations performed in each breathing phase. Given this

ner (Epson Group, Nagano, Japan) at 24 hr post irradiation.

strong agreement the planning system was utilized to quantify the

Dosimetric accuracy was veriﬁed using chamber measurements and 1D gamma analysis of ﬁlm insert dosimetry. Gamma

dose distribution effects to the tumor and lung due to breathing
motion.

|

110

ARCHIBALD-HEEREN

ET AL.

T A B L E 1 Percentage variation in chamber measured dose from calculated phase dose for the tumor position in each phase of the 4DCT
dataset.
Dose variation from planned
Tumor chamber dose

Inferior 2 cm

Inferior 1 cm

Plan geometry

Superior 1 cm

Superior 2 cm

Average variation

10 9 10

1.9%

0.7%

0.7%

0.8%

2.3%

1.3%

GTV

5.1%

1.0%

0.5%

2.2%

3.7%

2.5%

ITV

0.5%

1.9%

0.9%

1.9%

0.8%

1.0%

Average

3.3%

3.2%

3.0%

1.5%

0.8%

1.4%

Lung override

5.7%

1.7%

1.8%

0.9%

1.0%

1.4%

Robust all

1.2%

0.2%

1.8%

0.1%

0.3%

0.0%

2.4%

1.0%

2.4%

0.9%

0.8%

0.2%

Robust values

0.5%

1.4%

0.5%

0.0%

0.1%

0.2%

Average variation

0.7%

0.3%

0.5%

0.6%

0.5%

3.3%

1.7%

1.7%

1.2%

1.7%

Robust extremes

Standard deviation

T A B L E 2 Percentage variation in chamber measured dose from calculated phase dose for the lung position in each phase of the 4DCT
dataset.
Dose variation from planned
Lung chamber dose

Inferior 2 cm

10 9 10

Inferior 1 cm

Plan geometry

Superior 1 cm

Superior 2 cm

Average variation

3.2%

1.3%

1.6%

0.2%

0.3%

0.7%

GTV

0.1%

0.5%

3.1%

3.9%

3.1%

1.9%

ITV

0.6%

3.2%

4.2%

2.8%

2.2%

1.3%

Average

0.7%

2.6%

2.7%

1.6%

1.6%

0.8%

Lung override

0.6%

0.9%

1.2%

2.1%

2.2%

0.6%

Robust all

0.8%

2.0%

3.6%

1.8%

1.6%

1.9%

Robust extremes

1.4%

1.2%

2.6%

1.5%

1.0%

1.1%

Robust values

0.7%

2.9%

2.0%

2.7%

2.1%

0.9%

Average variation

0.7%

1.0%

2.3%

2.0%

1.8%

Standard Deviation

1.4%

1.9%

1.6%

1.2%

0.9%

T A B L E 3 1D Gamma analysis of calculated vs ﬁlm measured central axis dose proﬁles in plane of travel.
3%/3 mm gamma result (% points passed)
Plan
10 9 10

Inferior 2 cm
95.8

Inferior 1 cm
100

Plan geometry
98

GTV

93

91

99.7

ITV

100

100

91.7

99
100
96.9

Superior 2 cm
98.7
100
98.8

Average gamma

Standard deviation

98.3

1.6

96.7

4.4

97.5

3.5

Average

99.9

95.7

96.7

88.2

96.1

4.8

Lung override

93.7

96.7

81.4

96.7

99.1

93.52

7.0

Robust all

97.7

97.5

91.3

97

100

96.7

3.2

Robust ext

89.3

91.6

93.5

95.5

100

94.0

4.1

Robust values

97

99.9

2.0

Average gamma

95.8

96.6

3.7

3.6

Standard deviation

100

Superior 1 cm

100

95.3

98.2

98.1

94.5

97.1

97.9

96.4

6.4

1.6

4.0

1.8

Tumor dose variations for the various planning techniques are

Adequate tumor coverage (>95%) was achieved across all breath-

shown in Figs. 6 and 7. Variations from the central planned dose are

ing cycles in all plans with the exception of the GTV and Lung over-

displayed as a demonstration of the robustness of both coverage and

ride plans. Both optimization techniques resulted in substantial

resultant dose escalation from the investigated effect of tumor motion.

reduction in tumor coverage with tumor motion.
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Tumor dose variation was larger in the travel toward air in com-
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4 | DISCUSSION

parison to lung, resulting in variations in maximum dose from plan of
9, 5, 8% into lung and 26, 22, and 21% into air for GTV, ITV, and
average plans respectively.

4.A | Dose accuracy
Of the 40 central GTV measurements the mean variation from calculated dose was 0.0%  2.3%. The GTV plan showed the poorest

3.B.3 | Lung dose distributions
Measurements of lung maximum and mean dose variations are displayed in Figs. 8 and 9.

agreement with an average 2.5% dose escalation from planned and a
signiﬁcant 5.1% dose discrepancy in the 2 cm inferior geometry.
Measurement of lung doses shows excellent agreement with calculation. Over all measurements the average discrepancy between

The GTV plan resulted in the lowest mean dose to the lung, a

measured and calculated dose was 1.1%  1.9%. All chamber mea-

natural result of the reduced length of treatment. Of the remaining

surements taken showed agreement within the uncertainty range

methodologies the ITV, lung override, and robust optimization across

6%, with a maximum discrepancy of 5.7%.

all datasets resulted in a decrease in mean lung dose of over 1.5 Gy
from the average dataset methodology.

1D gamma analysis results for all 40 delivered breathing cycles
are shown in Table 3. Excellent agreement is seen across all dose

The average plan methodology produced the highest lung max

proﬁles with an average of 96.4% of all points passing the 3%/3 mm

dose in all breathing cycles. In all but one case the ITV plan method-

criteria, and only 2 of 40 plans resulting in a pass rate under 90%.

ology produced higher lung maximum doses than the robust opti-

The worst performing result was recorded with the lung override

mization methodologies.

technique in the central geometry.

F I G . 6 . Planned 98% coverage of GTV
with tumor displacement.

F I G . 7 . Planned GTV 2% Dose with
tumor displacement.
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The results demonstrate that the TPS accurately models the

A possible explanation for the signiﬁcant dose escalation is pre-

delivered dose in the offset geometries for all plans. This provides

sented by the authors. Work by Hunt et al65 showed reduced dose

the foundation for analysis of plans primarily through the Raystation

in regions adjacent to a low density inhomogeneity where the low

planning system calculated doses.

density results in fewer electron interactions to deposit energy,
greater electron path length and a potential loss of electron equilib-

4.B | Plan dosimetry

rium. As a result, in the optimization phase additional photon ﬂuence
is required to provide equivalent dose to lung tissue and adjacent

The gamma analysis curves in Fig. 10 show the agreement

soft tissue. The effect can be paralleled to the work performed by

between planned and delivered dose for the 2 cm offset toward

both Thomas and Hoole44 and Byrne et al45 on the effects of opti-

the optimized air cavity for three different plans, verifying the

mizing to the edge of skin/surface interfaces. The presented results

effect is a real delivery consequence rather than solely computa-

for internal optimization suggest that the effect is not limited to the

tional error. It can be seen that the 130% dose escalation

external surface, but may also be present at depth given the exis-

greater than that planned seen in the GTV and ITV plans are

tence of sufﬁcient air or low density lung inhomogeneity. The issue

avoided in the robust optimization plan. This is an extreme sce-

occurs in phases where the GTV moves into a space optimized to air

nario in which a 2.5 cm diameter cylinder of air resides adjacent

or lung tissue, where the resultant increase in electron scattering

to the tumor volume, and therefore may be clinically unrealistic.

(i.e., build up and lateral scatter) due to signiﬁcantly increased den-

However, results in Fig. 11 show a decreased, yet similar effect

sity results in dose escalation. When smaller targets traverse into

with optimization to lung (Plan GTV and ITV inferior shifts). The

regions that were optimized to lung density, considerable differences

results show parallels to previous published literature64 demon-

from the prescribed dose can occur. Such an effect is clearly repre-

strating large increases in max doses when optimizing to lung

sented in the DVH distributions presented in Fig. 11 for the ITV,

volumes.

GTV and average dataset optimized plans.

F I G . 8 . Mean Lung dose with tumor
motion displacement.

F I G . 9 . Maximum (0.03 cm3 volume)
dose to lung (excluding GTV) with tumor
motion displacement.
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It should be noted that the effect does not appear to be linear in

dose across the breathing cycle. Robust planning performed particu-

nature. Dose escalations when optimizing to air, 0.2 g/cm3 lung, and

larly favorably in the presence of large tumor position variations,

0.6 g/cm3 lung were 25, 9, and 0%, respectively, compared with

both superiorly and inferiorly, compared with maximum variations of

qtissue

qtissue

of 1000, 5, and 1.66. Dose escala-

25 and 8% for the GTV planning technique, 25 and 4% for the ITV

tion is most exaggerated at edge of ﬁeld boundaries. This suggests a

technique and 23 and 5% for the average dataset planning tech-

further effect at penumbra regions where lateral electron equilibrium

nique.

ratios of

qair¼0:001 , qlung¼0:2

and

qtissue

qlung¼0:6

is lost as a result of multileaf collimator or jaw shielding.

GTV and lung override techniques resulted in insufﬁcient dose

Further work is required to determine the magnitude of dose

coverage of the target over the full range of travel. Whilst this is

spikes in the presence of optimization to internal air cavities and low

expected for the GTV plans, this result suggests that a lung override

density geometries. It is likely that the signiﬁcance of such effects is

technique is suboptimal when tumor motion is large. All other plans

impacted by a range of factors including cavity size, density of sur-

provided suitable coverage to the tumor across the entire motion.

rounding tissue, beam quality, and the presence of electron equilib-

For the average density datasets and ITV plans this coverage was

rium conditions. Outside of the lung this effect may play a role in

achieved at the cost of large dose variations in the doses to the

other low density regions such as sinus cavities or air in rectum and

GTV along its travel. In contrast, robust plans showed stable mean

cervix patients.

and max lung doses across all tumor breathing cycles. With regards

In cases where large air cavities are included in the PTV within

to tumor dose distribution and lung doses the robust plans provided

lung, such as large airways at medial lung disease, there is a clear

more stable dose distributions across all positional offsets, allowing

and clinically signiﬁcant dose variation. Robust optimization may be

for tumor dose coverage without large dose escalation.

one suitable solution for such scenarios. The distributions in

Whether such an improvement is clinically signiﬁcant is difﬁcult

Figs. 6–9 show signiﬁcant reductions in the impact of such effects in

to ascertain. The dose escalation of in-air optimization for GTV, ITV

the presence of tumor motion using robust optimization. All three

and average datasets in the superior offset geometries would be

robust methodologies displayed signiﬁcantly less variation in max

considered clinically signiﬁcant in almost all cases at over 20%

FIG. 10.

1D dose proﬁles and gamma analysis for 2 cm sup plans of (a) Robust All, (b) GTV and (c) ITV optimization methodologies.

F I G . 1 1 . Dose Volume Histogram
distributions of dose to the primary tumor,
ipsilateral lung, and heart through
breathing cycles 2 cm superior (air
optimization) and inferior (lung
optimization) for (a) GTV plans (b) ITV
plans (c) Robust planning across all scans
and (d) Average datasets.
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variation. For the lung based optimization with dose escalations

the RayStation treatment planning system across ﬁve breathing

between 4 and 8% the blurring of dose across the breathing cycle

cycles.

will lead to a reduction in such a maximum. It is not the aim of this

Chamber and ﬁlm measurements were used to verify the accu-

paper to produce weighted doses in line with breathing cycle such

racy of the RayStation calculations for each of the plans in each of

as in work by Bortfeld et al.42 However, given a sinusoidal breathing

the ﬁve breathing cycles. The chamber measurements show excel-

distribution such as outlined by Chan et al.51 it is not unreasonable

lent agreement with the calculated dose with an average discrepancy

to expect the probability of the tumor to be in the full extents of

of 0.0%  2.3% in the tumor and 1.1%  1.9% in lung. Gamma

motion to around 30–40%, providing a dose variation over the

analysis performed between calculated and measured ﬁlm dosimetry

breathing cycle of 3–4%. These motions also represent an extreme

resulted in an average pass rate of 96.4% for 3%/3 mm criteria, with

at a total of 4cms travel. At 1 cm superior and inferior the dose

2/40 comparisons recording pass rates under 90%.

escalation results were signiﬁcantly reduced, though still considerable for air optimization.

Plans optimized using minimum dose constraints to low density
volumes resulted in large dose escalations once occupied by the

Robust optimization may have a considerable role to play in

moving tissue density target. Dose escalations of up to 22% above

breath hold techniques given the extreme dose escalation seen in

planned calculation doses were noted in plans optimized to low den-

the GTV cases, even in the presence of smaller tumor motion. Fur-

sity ITVs and average density datasets. Where possible target vol-

ther dose calculation effects may arise as a result of increased air

umes should exclude air cavities in the lung such as bronchial

pressure in the lungs and a reduced overall lung tissue density. The

airways.

optimization across a breath hold and 1–2 maximum inhale 4DCT

Plans in which the ITV was overridden to an intermediate density

bins in planning may provide stable dose distributions, and reduced

resulted in reduced dose escalation but an under dose to the GTV

treatment times whilst maintaining tissue sparing.

through the breathing cycle.
Robust optimization provides greater stability in dose for large

4.C | Further considerations

tumor motion. In the presence of smaller tumor motion of <1 cm,
the effect was less signiﬁcant. In areas where the PTV covered an

This study has intentionally focused on an extremely simple repre-

air volume. Tumors with large motion and large density variations in

sentation of the problem of optimization and tumor motion. Further

surrounding tissue may result in signiﬁcant improvements in dose

to the target motion itself, the travel of surrounding tissue may have

stability with implementation of robust optimization.

an equally large impact on the stability of the intended planned
DVH distributions. Cases in which the motion of the heart traverses
across several VMAT segments may have a signiﬁcantly larger
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expansion to account for slight changes in tumor motion and daily
setup uncertainties as documented by Ruben et al.9 Work by
McCann66 and Chan51 have shown that such uncertainties can be
accounted for with reduced tissue doses by escalating dose to the
edges of the GTV. Therefore, a potentially ideal solution for future
investigation is the optimization across the 4DCT dataset with intentional dose escalation at the maximum extent of travel. This implementation in a current ITV approach may lead to even greater dose
inhomogeneity than found in this work, and as such care should be
taken.

5 | CONCLUSION
A range of optimization techniques, including implementation of
robust optimization, were used to create VMAT deliveries for moving targets in a lung phantom. All plans have been recalculated in
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